Kairos Pharma, LTD. (KAPA) stock
KAPANYSEPharmaceutical PreparationsFiscal year ends December 31
$0.40−0.01 (-1.70%)
Close on Nov 17, 2026Market cap $1.49MP/E –Yield –
Kairos Pharma enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Kairos Pharma's enterprise value was $8.30M on Nov 11, 2026, against $115.93M a year earlier. Over the last 2 years it ranged from $8.30M to $164.64M, with a median of $88.75M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $8.30M | -91.5% |
| 2025 | Dec 31, 2025 | $97.91M | -26.6% |
| 2024 | Dec 31, 2024 | $133.47M | – |
See a number that looks wrong?